SCHEMBL18587883

SCHEMBL18587883

Cn1c2cccc(-c3ccc4c(c3)-c3ccccc3-c3ccccc3-c3ccccc3-4)c2c2c3ccccc3c3ccccc3c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH5 Q6P6C2 1/20 0.41
FTO Q9C0B1 1/20 0.41
RET P07949 2/20 0.37
IDO1 P14902 2/20 0.37
HSP90AA1 P07900 1/20 0.37
MAPT P10636 4/20 0.36
KDM4E B2RXH2 1/20 0.36
GPR3 P46089 1/20 0.34
HSD17B10 Q99714 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPK1 P28482 2/20 0.34
LMNA P02545 2/20 0.34
RAB9A P51151 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
PKM P14618 1/20 0.34
MDM2 Q00987 1/20 0.34
MCL1 Q07820 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HTT P42858 2/20 0.33
L3MBTL1 Q9Y468 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18566308 0.85 GPR3 (0.37) ALKBH5FTORETIDO1HSP90AA1
SCHEMBL18565481 0.84 ALKBH5 (0.35) ALKBH5FTORETIDO1HSP90AA1
SCHEMBL18565475 0.83 ALKBH5 (0.35) ALKBH5FTORETIDO1HSP90AA1
SCHEMBL18565493 0.83 ALKBH5 (0.35) ALKBH5FTORETIDO1HSP90AA1
SCHEMBL18565484 0.83 ALOX5 (0.39) ALKBH5FTORETIDO1HSP90AA1
SCHEMBL18588308 0.82 GPR3 (0.47) ALKBH5FTORETMAPTKDM4E
SCHEMBL18565482 0.82 ALOX5 (0.38) ALKBH5FTORETIDO1HSP90AA1
SCHEMBL18566287 0.81 KDM4E (0.43) ALKBH5FTORETIDO1HSP90AA1
SCHEMBL18565480 0.81 ALKBH5 (0.33) ALKBH5FTORETIDO1HSP90AA1
SCHEMBL18565495 0.81 ALKBH5 (0.33) ALKBH5FTORETIDO1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 ALKBH5 265/4885FTO 202/4885RET 1581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.